Recent Deals Suggest Proteomics, Life-Science Markets May be Poised to Renew M&A Activity | GenomeWeb

This story originally ran on Sept. 21.

By Tony Fong

Are proteomics and other life-science firms ready to shop again?

Earlier this month Danaher announced plans to purchase the Applied Biosystems/MDS mass spectrometry joint venture and MDS' Analytical Technologies division for $1.1 billion, creating a new alpha male in the proteomics and life-science space.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: genetic analysis of pollutant-tolerant fish, and more.

Researchers have found a rare carbapenem resistance gene on a US pig farm, NBC News reports.

New York officials are considering the use of a familial DNA search to get a lead on a suspect in the strangulation death of a runner.

In Nature this week: genome-wide transcriptome analysis of brain samples from people with autism spectrum disorder, flounder genome, and more.